Silvio E. Perea

1.3k total citations
43 papers, 772 citations indexed

About

Silvio E. Perea is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Silvio E. Perea has authored 43 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 17 papers in Oncology and 13 papers in Immunology. Recurrent topics in Silvio E. Perea's work include interferon and immune responses (8 papers), Cancer-related Molecular Pathways (7 papers) and Peptidase Inhibition and Analysis (5 papers). Silvio E. Perea is often cited by papers focused on interferon and immune responses (8 papers), Cancer-related Molecular Pathways (7 papers) and Peptidase Inhibition and Analysis (5 papers). Silvio E. Perea collaborates with scholars based in Cuba, Argentina and Spain. Silvio E. Perea's co-authors include Yasser Perera, Daniel F. Alonso, Hernán G. Fariña, Boris Acevedo, Paola Massimi, Lawrence Banks, Osvaldo Reyes, Roberto Gómez, Carmen Valenzuela and Idania Baladrón and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Silvio E. Perea

43 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvio E. Perea Cuba 17 547 225 164 102 81 43 772
Rajesh Vij United States 10 365 0.7× 265 1.2× 104 0.6× 58 0.6× 85 1.0× 13 726
Ding Ma China 17 557 1.0× 198 0.9× 151 0.9× 82 0.8× 166 2.0× 33 915
Robert A. Olie Switzerland 16 1.1k 2.0× 361 1.6× 153 0.9× 81 0.8× 93 1.1× 26 1.3k
Francesca Di Stefano United Kingdom 6 476 0.9× 212 0.9× 87 0.5× 44 0.4× 52 0.6× 12 679
Ciara Ryan Ireland 11 442 0.8× 178 0.8× 77 0.5× 58 0.6× 143 1.8× 29 750
Nadine Hein Australia 14 849 1.6× 278 1.2× 59 0.4× 148 1.5× 115 1.4× 36 1.1k
Alessandro Natoni Ireland 18 701 1.3× 269 1.2× 332 2.0× 64 0.6× 90 1.1× 43 1.1k
Deborah Silvera United States 11 941 1.7× 227 1.0× 105 0.6× 91 0.9× 179 2.2× 14 1.3k
Max Koeppel Germany 10 500 0.9× 298 1.3× 172 1.0× 60 0.6× 197 2.4× 20 768
Wade Diehl United States 9 367 0.7× 260 1.2× 62 0.4× 87 0.9× 52 0.6× 12 843

Countries citing papers authored by Silvio E. Perea

Since Specialization
Citations

This map shows the geographic impact of Silvio E. Perea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvio E. Perea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvio E. Perea more than expected).

Fields of papers citing papers by Silvio E. Perea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvio E. Perea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvio E. Perea. The network helps show where Silvio E. Perea may publish in the future.

Co-authorship network of co-authors of Silvio E. Perea

This figure shows the co-authorship network connecting the top 25 collaborators of Silvio E. Perea. A scholar is included among the top collaborators of Silvio E. Perea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvio E. Perea. Silvio E. Perea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perez, George, Chen‐Liang Deng, Ying Yi, et al.. (2024). Deregulation of Casein Kinase-2 in non-small-cell lung cancer: A subunit-specific analysis. 3(4). 4571–4571. 1 indexed citations
2.
Perez, George, Vladimir Besada, Luis Javier González, et al.. (2022). CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model. Biomedicines. 11(1). 43–43. 5 indexed citations
3.
Perez, George, Yassel Ramos, Viviana Falcón, et al.. (2022). Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection. Viruses. 14(3). 552–552. 9 indexed citations
4.
Besada, Vladimir, George Perez, Yassel Ramos, et al.. (2021). Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945. Cells. 10(2). 338–338. 8 indexed citations
5.
Perez, George, Vladimir Besada, Yassel Ramos, et al.. (2021). Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300. Biomedicines. 9(7). 766–766. 13 indexed citations
6.
Perea, Silvio E., et al.. (2019). Immunogenic Cell Death: An opportunity for Clinical Oncology?. Bionatura. 4(4). 958–959. 1 indexed citations
7.
Garay, Hilda, Luis Ariel Espinosa, Yasser Perera, et al.. (2018). Characterization of low‐abundance species in the active pharmaceutical ingredient of CIGB‐300: A clinical‐grade anticancer synthetic peptide. Journal of Peptide Science. 24(6). e3081–e3081. 12 indexed citations
8.
Perea, Silvio E., Idania Baladrón, Carmen Valenzuela, & Yasser Perera. (2018). CIGB-300: A peptide-based drug that impairs the Protein Kinase CK2-mediated phosphorylation. Seminars in Oncology. 45(1-2). 58–67. 40 indexed citations
9.
Perera, Yasser, Seidy Pedroso‐Santana, Orlando Borrás‐Hidalgo, et al.. (2015). Pharmacologic inhibition of the CK2-mediated phosphorylation of B23/NPM in cancer cells selectively modulates genes related to protein synthesis, energetic metabolism, and ribosomal biogenesis. Molecular and Cellular Biochemistry. 404(1-2). 103–112. 8 indexed citations
10.
Perera, Yasser, et al.. (2014). Implementation of a competitive ELISA for pharmacokinetics studies of CIGB-300 in human plasma. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Perera, Yasser, et al.. (2014). Synergistic interactions of the anti-casein kinase 2 CIGB-300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models. Molecular and Clinical Oncology. 2(6). 935–944. 23 indexed citations
12.
Fariña, Hernán G., Yasser Perera, Silvio E. Perea, et al.. (2011). CIGB-300, a proapoptotic peptide, inhibits angiogenesis in vitro and in vivo. Experimental Cell Research. 317(12). 1677–1688. 19 indexed citations
13.
Perera, Yasser, Hernán G. Fariña, Jeovanis Gil, et al.. (2009). Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity. Molecular Cancer Therapeutics. 8(5). 1189–1196. 47 indexed citations
14.
González, Luis Javier, Lila Castellanos‐Serra, Volker Badock, et al.. (2003). Identification of nuclear proteins of small cell lung cancer cell line H82: An improved procedure for the analysis of silver‐stained proteins. Electrophoresis. 24(1-2). 237–252. 24 indexed citations
15.
Díaz, Yanelys Morera, et al.. (2001). P27kip1: regulation and function of a cell cycle key regulationn. Biotecnología aplicada. 18(4). 193–202. 3 indexed citations
16.
López-Ocejo, Omar, et al.. (2000). Impaired Angiogenic Balance and Suppression of Tumorigenicity in HeLa Cells Chronically Exposed to Interferon-α. Biochemical and Biophysical Research Communications. 277(2). 410–416. 4 indexed citations
17.
Calixto, Andrea, et al.. (1998). Differential Expression of the p27Kip1mRNA in IFN-Sensitive and Resistant Cell Lines. Biochemical and Biophysical Research Communications. 245(3). 752–756. 8 indexed citations
18.
García-Milian, Rolando, et al.. (1996). Modulation of Human Papillomavirus Type 16 mRNA in Cervical Invasive Carcinoma Patients by Interferon-α Therapy. Journal of Interferon & Cytokine Research. 16(9). 739–743. 8 indexed citations
19.
Perea, Silvio E., et al.. (1995). Interferon-αElicits Downregulation of Human Papillomavirus 18 mRNA in HeLa Cells by Selective Repression of Endogenous Viral Transcription. Journal of Interferon & Cytokine Research. 15(6). 495–501. 9 indexed citations
20.
Perea, Silvio E., et al.. (1993). Partial Phenotypic Reversion of HeLa Cells by Long-Term Interferon-α Treatment. Journal of Interferon Research. 13(5). 369–375. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajesh Vij Breakdown of academic impact, for papers by Ding Ma Breakdown of academic impact, for papers by Robert A. Olie Breakdown of academic impact, for papers by Francesca Di Stefano Breakdown of academic impact, for papers by Ciara Ryan Breakdown of academic impact, for papers by Nadine Hein Breakdown of academic impact, for papers by Alessandro Natoni Breakdown of academic impact, for papers by Deborah Silvera Breakdown of academic impact, for papers by Max Koeppel Breakdown of academic impact, for papers by Wade Diehl
Rankless by CCL
2026